Literature DB >> 192882

Effects of guanidine on transmitter release and neuronal excitability.

G Matthews, W O Wickelgren.   

Abstract

1. Guanidine hydrochloride (CH5N3-HCl) was applied to frog neuromuscular junctions blocked by reduced external Ca2+, or increased external Mg2+ concentration, or by both. Guanidine produced a dose-dependent increase in the average number of quanta released by presynaptic action potentials, the threshold dose being 0-1-0-2 mM. No post-synaptic effects were observed. 2. Guanidine also increased the excitability of the motor nerve fibres, as evidenced by multiple firing to single electrical stimuli and finally by spontaneous action potentials. These effects were studied in greater detail in giant axons (Müller axons) in the spinal cord of lamprey. Exposure to guanidine produced in these axons a progressive increase in excitability, manifested by repetitive firing to a single electrical stimulus, spontaneous membrane potential oscillations and spontaneous bursts of action potentials. Guanidine had no effect on the resting potential. 3. The effect of guanidine on the excitability of Müller axons was mimicked in every detail simply by reducing the divalent cation concentration of the bathing solution. 4. Guanidine also produced dose-dependent increases in the duration of action potentials in Müller axons. This effect always preceded in time the appearance of the excitability effects and was not mimicked by reducing the divalent cation concentration. It is suggested that the broadening of the action potential is separate from the excitability effects and may reflect a decrease of delayed rectification. 5. Guanidine (0-3 mM) increased the frequency of miniature end-plate potentials (min. e.p.p.) in solutions containing 2-11 mM-K+ in such a way as to shift the relationship between min. e.p.p. frequency and extracellular K+ toward lower values of K+. This effect was interpreted to mean that guanidine produced a depolarization of the nerve terminal which summed with the depolarization produced by a given concentration of K+. The calculated depolarization produced by 0-3 mM guanidine was 5-7 mV. 6. The effects of guanidine on evoked transmitter release, excitability, and min. e.p.p. frequency are consistent with a hypothesis which states that guanidine binds at or near fixed negative changes on the outside of nerve membrane and reduces the screening effect of divalent cations.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 192882      PMCID: PMC1283553          DOI: 10.1113/jphysiol.1977.sp011756

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  18 in total

1.  Changes in potassium concentration around motor nerve terminals, produced by current flow, and their effects on neuromuscular transmission.

Authors:  A TAKEUCHI; N TAKEUCHI
Journal:  J Physiol       Date:  1961-01       Impact factor: 5.182

2.  The effect of guanidine on neuromuscular transmission.

Authors:  M OTSUKA; M ENDO
Journal:  J Pharmacol Exp Ther       Date:  1960-03       Impact factor: 4.030

3.  The action of calcium on the electrical properties of squid axons.

Authors:  B FRANKENHAEUSER; A L HODGKIN
Journal:  J Physiol       Date:  1957-07-11       Impact factor: 5.182

4.  The effect of calcium on the myelinated nerve fibre.

Authors:  B FRANKENHAEUSER
Journal:  J Physiol       Date:  1957-07-11       Impact factor: 5.182

5.  Changes in end-plate activity produced by presynaptic polarization.

Authors:  J DEL CASTILLO; B KATZ
Journal:  J Physiol       Date:  1954-06-28       Impact factor: 5.182

6.  Spontaneous subthreshold activity at motor nerve endings.

Authors:  P FATT; B KATZ
Journal:  J Physiol       Date:  1952-05       Impact factor: 5.182

7.  Negative surface charge near sodium channels of nerve: divalent ions, monovalent ions, and pH.

Authors:  B Hille; A M Woodhull; B I Shapiro
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1975-06-10       Impact factor: 6.237

8.  Quantal components of end-plate potentials in the myasthenic syndrome.

Authors:  E H Lambert; D Elmqvist
Journal:  Ann N Y Acad Sci       Date:  1971-09-15       Impact factor: 5.691

9.  Detailed analysis of neuromuscular transmission in a patient with the myasthenic syndrome sometimes associated with bronchogenic carcinoma.

Authors:  D Elmqvist; E H Lambert
Journal:  Mayo Clin Proc       Date:  1968-10       Impact factor: 7.616

10.  Tetrodotoxin-resistant electric activity in presynaptic terminals.

Authors:  B Katz; R Miledi
Journal:  J Physiol       Date:  1969-08       Impact factor: 5.182

View more
  9 in total

1.  On the effect of calcium on the frequency of miniature end-plate potentials at the frog neuromuscular junction.

Authors:  G Matthews; W O Wickelgren
Journal:  J Physiol       Date:  1977-03       Impact factor: 5.182

2.  The effect of guanidine on transmitter release in the ciliary ganglion of the chick.

Authors:  F W Banks
Journal:  J Physiol       Date:  1978-05       Impact factor: 5.182

3.  Potentiation by 4-aminopyridine of quantal acetylcholine release at the Torpedo nerve-electroplaque junction.

Authors:  D Muller
Journal:  J Physiol       Date:  1986-10       Impact factor: 5.182

4.  Ion dependence of the release of noradrenaline by tetraethylammonium and 4-aminopyridine from cat splenic slices.

Authors:  V Ceña; A G García; C Gonzalez-Garcia; S M Kirpekar
Journal:  Br J Pharmacol       Date:  1985-02       Impact factor: 8.739

5.  Effects of the facilitatory compounds catechol, guanidine, noradrenaline and phencyclidine on presynaptic currents of mouse motor nerve terminals.

Authors:  A J Anderson; A L Harvey
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1988-08       Impact factor: 3.000

6.  Three potassium currents in mouse motor nerve terminals.

Authors:  N Tabti; C Bourret; A Mallart
Journal:  Pflugers Arch       Date:  1989-02       Impact factor: 3.657

7.  Ciguatoxin enhances quantal transmitter release from frog motor nerve terminals.

Authors:  J Molgó; J X Comella; A M Legrand
Journal:  Br J Pharmacol       Date:  1990-04       Impact factor: 8.739

8.  Effect of guanidine on release of noradrenaline from the perfused spleen of the cat.

Authors:  J Hirsch; S M Kirpekar; J C Prat
Journal:  Br J Pharmacol       Date:  1979-08       Impact factor: 8.739

9.  Guanidine affects differentially the twitch response of diaphragm, extensor digitorum longus and soleus nerve-muscle preparations of mice.

Authors:  Rosana Ferrari; Léa Rodrigues-Simioni; Maria Alice da Cruz Höfling
Journal:  Molecules       Date:  2012-06-15       Impact factor: 4.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.